Robarts Clinical Trials Inc. moves downtown

Robarts Clinical Trials Inc., a global academic clinical research organization with offices in San Diego, Amsterdam and London, Ont., announced today a relocation to the Bell Canada Building in downtown London, effective Jan. 1, 2016.

The new corporate headquarters, located at 100 Dundas St., will provide capacity for increased customer support, clinical operations, business development and leadership functions across the company and will accommodate Robarts Clinical Trials’ rapid growth and future expansion plans. Its headquarters is currently located at Western.

An operationally and financially independent subsidiary of Western, Robarts Clinical Trials was established in 1986 at the Robarts Research Institute and has been part of the Schulich School of Medicine & Dentistry since 2007.

“The new office will allow increased capabilities in areas that align with our strategic needs. This facility will allow expansion of project teams to support growth and provide dedicated space for customer briefings and other essential activities,” said Brian Feagan, CFO and scientific director. “The team is excited about our scientific accomplishments and the growth record. This move is a commitment to continued excellence in clinical research.”

Since 2013, the company’s staff has more than doubled, further necessitating the move. Currently, there are 90 people working in the London head office and this number will continue to grow leading up to the downtown move. An additional 30 employees are employed at its San Diego and Amsterdam offices.

Robarts Clinical Trials provides expertise in study design, implementation and interpretation to public and private sector sponsors and academic investigators. The company is currently working with six of the world’s 10 most well-recognized pharmaceutical companies and to date collaborates internationally with more than 1,200 hospitals and clinics around the world on every continent except Antarctica.